Stay updated on Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Sign up to get notified when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.

Latest updates to the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page
- Check5 days agoChange DetectedA new revision entry, Revision: v3.5.4, was added to the study's Record History, and the previous Revision: v3.5.3 entry was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s displayed revision/version number was updated from “v3.5.2” to “v3.5.3,” indicating a maintenance or software update without altering the recorded trial information.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check41 days agoChange DetectedThe history shows the study is completed with updates to Study Status, Study Design, and Contacts/Locations. Earlier status and sponsor-related details were removed or revised to reflect the current record.SummaryDifference0.8%

- Check63 days agoChange DetectedAdded revision v3.5.0 to the record history and removed revision v3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedA new Revision: v3.4.3 is now shown in the history. Revision: v3.4.2 has been removed.SummaryDifference0.1%

Stay in the know with updates to Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenolanib With Chemotherapy in Resistant FLT3 AML Clinical Trial page.